Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001517800 | SCV001726374 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001517800 | SCV004700306 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | ZNF341: BP4, BP7 |
Breakthrough Genomics, |
RCV001517800 | SCV005315125 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001517800 | SCV001927641 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001517800 | SCV001971872 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003908852 | SCV004726619 | likely benign | ZNF341-related disorder | 2019-06-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |